Skip to main content
News Icon

News categories: Publication

Special diet against asthma - publication in Immunity

Can a special diet help in certain cases of asthma? A new study at the University of Bonn at least points to this conclusion. According to the study, mice that were switched to a so-called ketogenic diet showed significantly reduced inflammation of the respiratory tract. The results are now published in the renowned journal "Immunity".

Asthma patients react even to low concentrations of some allergens with severe inflammation of the bronchi. This is also accompanied by increased mucus production, which makes breathing even more difficult. A central role here is played by cells of the innate immune system, which were only discovered a few years ago and are called Innate Lymphoid Cells (ILC). They perform an important protective function in the lungs by regenerating damaged mucous membranes. For this purpose they produce inflammatory messengers from the group of cytokines, which stimulate division of the mucosal cells and promote mucus production.

This mechanism is normally very useful: It allows the body to quickly repair damage caused by pathogens or harmful substances. The mucus then transports the pathogens out of the bronchial tubes and protects the respiratory tract against re-infection. "With asthma, however, the inflammatory reaction is much stronger and longer than normal", emphasizes Prof. Dr. Christoph Wilhelm from the Institute for Clinical Chemistry and Clinical Pharmacology, who is a member of the Cluster of Excellence ImmunoSensation at the University of Bonn. The consequences are extreme breathing difficulties, which can even be life-threatening.


Publication

Fotios Karagiannis, Schekufe Kharabi Masouleh, Klaus Wunderling, Jayagopi Surendar, Vanessa Schmitt, Alexander Kazakov, Marcel Michla, Michael Hölzel, Christoph Thiele & Christoph Wilhelm: Lipid-droplet formation drives pathogenic group 2 innate lymphoid cells in airway inflammation; Immunity; DOI: 10.1016/j.immuni.2020.03.003

Related news

Pandyra Publication Graphical Abstract

News categories: Publication

Genetic mutation affects survival after viral infection

Scientists discovered that haploinsufficiency in the Pax5 gene affects antiviral responses. The study was led by Prof. Dr. Aleksandra Pandyra from the Institute of Clinical Chemistry and Clinical Pharmacology at the University Hospital Bonn in collaboration with Prof. Dr. Arndt Borkhardt, Clinic Director at the Pediatric Oncology at the University Hospital Düsseldorf. The findings were published in the latest edition of EMBO Molecular Medicine.
View entry
AG Kürthen Multiple Sclerosis Bonn

News categories: Publication

Potential target for MS therapy discovered

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, which are a type of white blood cell, play a role in the development of MS and are thus a target for therapies. Researchers at the University Hospital Bonn (UKB), the University of Bonn and the FAU Erlangen-Nuremberg identified the membrane protein MLC1 as a potential target antigen in MS. The results of the work have now been published in the renowned journal “Neurology Neuroimmunology & Neuroinflammation”.
View entry
NLRP3 Alzheimers McManus

News categories: Publication

Reducing Neuroinflammation Could Help Fight Alzheimer’s

Alzheimer’s disease is the most common cause of dementia. A promising approach for its treatment is the prevention of inflammatory processes in the brain. An international team of scientists around Dr. Róisín McManus, Prof. Eicke Latz and Prof. Michael Heneka now provide new evidence supporting this approach and potentially contributing to the development of more effective therapies. The results have now been published in the journal “Immunity”.
View entry

Back to the news overview